Equities

Plant Advanced Technologies PAT SA

Plant Advanced Technologies PAT SA

Actions
  • Price (EUR)11.40
  • Today's Change-0.300 / -2.56%
  • Shares traded0.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Nov 13 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Plant Advanced Technologies PAT SA is a France-based life sciences company focusing on eco-friendly plant extracts production for pharmaceutical and cosmetic industries. It is also engaged in the research and development in the field of plant biotechnology. The Company patented its own production technologies, such as PAT Plant Milking, active natural compounds production system based on roots exudation of plants grown hydroponically or PAT Friday, a recombinant protein expression system using natural protein excretion system of genetically modified carnivorous to produce outside their leaf, in a sterile closed pitcher, the protein of interest in liquid. In addition PAT is involved in the development and sale of know-how, licenses and sub-licenses for its technologies.

  • Revenue in EUR (TTM)2.53m
  • Net income in EUR1.09m
  • Incorporated2005
  • Employees27.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.